featured news

Saturday, May 28, 2022

Line 3 Mock-up

read more

feature 1

featured news

feature 2

featured news

feature 3

featured news

Saturday, May 28, 2022

central workplaces

read more

feature 5

our technological excellence as a CDMO

We are oncomed – a Contract Development and Manufacturing Organization (CDMO) specialized in aseptic processing of oncology injectables in clinical and commercial scales. We deliver drugs with high potent and cytotoxic characteristics to fight cancer, worldwide.

organic solvents handling

high-potent APIs

single-use systems

sensitive API handling

5 reasons why choose oncomed

5 reasons why choose oncomed

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies, therefore we offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment sizes and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies, therefore we offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment sizes and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

upcoming events

euroPLX Vienna

partnering

13 Jun – 14 Jun 2022

Vienna, Austria

The 79th Marketplace is an exchange for licenses, products, assets, distribution deals and other Pharma Business Opportunities ranging from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices.

news & stories

12. 5. 2022 | Articles

Line 3 Mock-up

After many years of planning and designing, we have successfully completed the mock-up of Line 3. Read the article about the process and challenges we were facing.
read text
10. 3. 2022 | Articles

Implementation of IDM in oncomed

What is the Indentity Management and what was our jouney during the implementation? Article focused on importance of IDM.
read text
24. 2. 2022 | News

oncomed in Czech Business and Trade magazine

Read the article where we speak about our journey, facility and future plans.    
read text